Navigation Links
Lollipop Breast Reduction Technique Reduces Recovery Time
Date:12/23/2013

BEVERLY HILLS, Calif., Dec. 23, 2013 /PRNewswire-iReach/ -- Dr. Applebaum's innovative minimal incision breast reduction technique, or lollipop breast reduction is designed to help patients suffering from neck and back pain as a result of large breasts. Benefits of the minimal incision breast reduction include minimal recovery time and scarring, and this procedure is oftentimes covered by a patient's insurance plan. 

Breast Reduction Surgery

Large breasts can cause significant neck and back pain for many women. Our Beverly Hills breast reduction surgery is a safe, permanent option for women who suffer from large, pendulous breasts. In the reduction mammoplasty procedure, a surgeon removes excess fat, skin and tissue from the breasts to achieve a natural, proportional breast size and look.

About the Lollipop Breast Reduction

With over twenty years of experience, Beverly Hills plastic surgeon Dr. Robert Applebaum has mastered the French technique, or minimal incision breast reduction. Dr. Applebaum prefers this breast reduction technique because it requires fewer incisions and results in only one small scar from the nipple down to the breast fold. Another benefit of the lollipop technique is that it allows for the shortest recovery time, with no dressings, bindings or draining.

Breast Reduction Surgery May Be Covered by Insurance

In many cases breast reduction is medically necessary and may be covered by a patient's health insurance. Consult with Dr. Applebaum's office to see if you can take advantage of your already met insurance deductible before the end of the year when scheduling this surgery.

About Dr. Robert Applebaum

Dr. Applebaum is a board-certified plastic surgeon with a Beverly Hills practice and over twenty years of experience performing surgical and non-invasive procedures including breast reductions, tummy tucks, facelifts, and laser treatments. He is a world-renowned surgeon, lecturer and educator who uses the latest and best procedures and technology to serve his international clientele

To learn more about Dr. Applebaum's breast reduction expertise and to see before and after breast reduction galleries, visit http://www.bhbreastreduction.com or contact info@applebaummd.com or call 310.956.4305. 

Media Contact: Robert Applebaum, Breast Reduction Beverly Hills, 310-956-4305, info@applebaummd.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Breast Reduction Beverly Hills
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Ventana receives FDA clearance for Estrogen Receptor (ER) Image Analysis and Digital Read Application for breast cancer
2. Monoclonal Antibodies Market in Breast Cancer to 2019
3. Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
4. Associates for Breast and Prostate Cancer Studies Honors Ann-Margret, Robert Wagner and Bill and Roseann Patterson at 24th Annual The Talk of the Town Gala
5. Edith Sanford Breast Cancer Partners with Athena Breast Health Network to Personalize Breast Cancer Risk Assessment
6. Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor
7. Computer-Aided Image Analysis Aims to Offer ‘Second Opinion’ in Breast Tumor Diagnosis
8. UE LifeSciences Launches WeMustTry.com Crowdfunding Campaign for Low-cost, Painless Breast Cancer Screening Services Focused on Developing Countries
9. Polaris Group Files New IND for ADI-PEG 20 in Breast Cancer
10. ResearchMoz: Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
11. Tennessee Breast Center Selects Sectra RIS/PACS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):